Healthcare Industry Stem Cell Market Research Report, 2024 | Page 2

Hexa Research

Fact-based market research, penetrating industry insights and validated forecasts to help you make better decisions for a stronger future
layers. Hence, they can produce any tissue or cell that the body has to repair itself. They are self-perpetuating, that is they can develop several copies of themselves.
Browse Details of Report @ https:// www. hexaresearch. com / research-report / stem-cellindustry
Embryonic stem cells are derived from the undifferentiated inner mass of cells present in a human embryo. Adult or somatic stem cells are found throughout the body and help regenerate damaged or dying cells & tissues. Adult stem cells are by far the most extensively used ones, because the human body can easily accept these cells. Furthermore, the possibility of contamination is also quite low. This segment will continue domina ting the global Stem Cell Market during the forecast period. It generated revenues exceeding USD 30 billion in 2013.
Based on technologies, the global industry is categorized into cryopreservation, cell production, expansion, and cell acquisition. The overall market was dominated by the cell acquisition segment in 2013. This is the technique of obtaining stem cells from their sources. Cell culture, cloning, and in-vitro fertilization are the different techniques of cell acquisition. Bone marrow harvesting too is an integral part of such a technique. Regenerative medicine, drug discovery, and drug development are the various application areas of the global market. Ongoing trends in medicine suggest that stem cell based treatments are gradually gaining much importance in the management of diseases, such as Huntington’ s chorea and Parkinson’ s disease.
Based on geographies, the global stem cell market is segmented into Europe, Asia Pacific, North America, and Rest of the World. In terms of revenue, North America holds the highest share in the overall market. The region may continue expanding robustly over the forecast period because of widespread adoption of cell based therapies and high R & D investments by the public & private sectors. Asia Pacific too may expand rapidly during the
Contact: + 1-800-489-3075
Email: sales @ hexaresearch. com Website: http:// www. hexaresearch. com /